Predictors of persistence in patients with schizophrenia treated with aripiprazole once-monthly long-acting injection in the Spanish clinical practice: a retrospective, observational study – CORRIGENDUM

This article when published failed to include the full list of Dr Ana González-Pinto’s affiliations, which are as follows:

• Hospital Universitario de Álava, Álava, Spain

• CIBERSAM, Biomedical Research Centre in Mental Health Network, Madrid, Spain

• Universidad del País Vasco, Álava, Spain

• IIS Bioaraba, Álava, Spain